RE:RE:Donnatal Permanent ImpairmentI am pretty sure they only paid US$250 million or so for this product in their early days.
ryehigh2014 wrote: Donnatal value to intangibles is ~$400MM - look at historical annual statements. For a product which generates 70MM (revised impairment after -14% YTD growth) Revenue annually I think this is fair. The asset is impaired over 15Y - 20Y
I do not expect that CXRX will be recording an impairment charge unless a material change occurs (FDA decides to pull it)